The Cancer Institute of New Jersey Robert Wood Johnson Medical School New Brunswick, New Jersey
Established in 1991, The Cancer Institute of New Jersey (CINJ) became an NCI-designated cancer center in 1997 and achieved comprehensive status in 2003. CINJ is part of the University of Medicine and Dentistry of New Jersey’s (UMDNJ) Robert Wood Johnson Medical School. Research at the Center is integrated with the Robert Wood Johnson University Hospital, School of Public Health, and several schools and departments of Rutgers, The State University of New Jersey, and Princeton University.
CINJ is dedicated to improving the prevention, detection, treatment, and care of patients with cancer, through the translation of laboratory discoveries into clinical practice. The research base of CINJ is organized into six programs: Cell Death and Survival Signaling; Genomic Instability and Tumor Progression; Cancer Pharmacology and Preclinical Therapeutics; Clinical Investigations; Carcinogenesis and Chemoprevention; and Cancer Prevention and Control.
Community outreach work at the Center includes smoking cessation programs and extends to the minority and underserved populations in New Jersey. CINJ offers clinical trials to cancer patients and has worked to increase the racial and ethnic diversity of cancer clinical trial populations statewide. Other outreach programs focus on the importance of early detection and screening for several types of cancer, as well as improving public education on ways to prevent cancer.
Cancer care is delivered to patients through a network of 16 hospitals across the state. CINJ’s principal affiliate, the Robert Wood Johnson University Hospital, provides the full range of clinical care to cancer patients. Multidisciplinary teams help patients make appropriate decisions and provide expert care with a full range of specialists.
CINJ offers the full spectrum of education and training programs for physicians, nurses, and scientists, including residencies in oncology specialties. CINJ also hosts two educational forums each year, bringing together leading experts in the cancer research field.
* This profile was provided by the Cancer Institute of New Jersey.
